 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 855089
Online Users : 977
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/4607
|
| Title: | Hyperuricemia and metabolic syndrome in the middle aged in Taiwan |
| Authors: | Shen, YH;Hsu, CM;Chen, YF;Chen, CY;Yao, CA;Lee, LT;Huang, KC |
| Contributors: | Division of Gerontology Research |
| Abstract: | Objectives: The relationship between serum uric acid levels and cardiovascular risk factors is complex. We examined the association between hyperuricemia and metabolic syndrome amongst apparently healthy Taiwanese aged from forty to sixty-five years. Research Design And Methods: This cross-sectional survey was based on a population from 4 nationwide health screening centers in Taiwan in 2000. A total of 4,466 subjects, aged 40 to 65 years were included. Blood pressure, body mass index (BMI), waist circumference, HDL cholesterol, serum triglycerides, and uric acid levels were measured. Hyperuricemia was defined as a serum uric acid level > or = 7.0 mg/dl (420 µmol/L) in men and > or = 6.0 mg/dl (360 µmol/L) in women, respectively. Metabolic syndrome was defined using the National Cholesterol Education Panel (NCEP) criteria or modified NCEP criteria (WC >90 cm in men and >80 cm in women).Results: The prevalence of hyperuricemia was 42.4% in men and 28.7% in women, respectively. The crude odds ratios (ORs) of metabolic syndrome was 2.79 (and 2.68 using the modified NCEP criteria) in subjects with hyperuricemia with increasing age (OR = 1.01-1.10) and BMI (OR = 1.39-1.47), the ORs of having metabolic syndrome increased significantly in each gender. After adjustment for age, gender, and BMI, the ORs of metabolic syndrome were significantly higher in subjects with hyperuricemia. Consclusions: The present study revealed that hyperuricemia was positively associated with metabolic syndrome and its individual factors. Therefore, serum uric acid levels may be applied as an additional evaluation for metabolic syndrome in a clinical setting. |
| Date: | 2008-05 |
| Relation: | International Journal of Obesity. 2008 May;32(Suppl. 1):S138. |
| Link to: | http://dx.doi.org/10.1038/ijo.2008.47 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0307-0565&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000255820100546 |
| Appears in Collections: | [陳慶餘(2006-2010)] 會議論文/會議摘要
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| ISI000255820100546.pdf | | 55Kb | Adobe PDF | 593 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
